Returning guest, Dr. Jeffrey Stark, M.D., Head of U.S. Medical Immunology at UCB discusses the new, ICD-10 sub-category, M45.A for non-radiographic axial spondyloarthritis (nr-axSpA), a chronic inflammatory condition affecting the spine and sacroiliac joint, and the importance of this development for physicians, patients, and their families. The new sub-category will be effective for diagnoses starting October 1, 2021.
Jeffrey Stark, MD, is the Head of Medical Immunology at UCB and is board-certified in both rheumatology and internal medicine. After completing training at Vanderbilt University and Emory University, he spent several years in full-time rheumatology practice in both private and academic clinical settings. In subsequent industry medical affairs roles, Dr. Stark has focused on medical education, advocacy, data generation, and highlighting the unmet needs of patients with immunologic diseases. In addition to his role at UCB, Dr. Stark serves as a board member of the American College of Rheumatology (ACR) Research Foundation and is a member of the Medical Advisory Board of the Georgia Chapter of the Lupus Foundation. Dr. Stark is also a past President of the Georgia Society of Rheumatology.